COMP <GO>
EYE vs UNH // ALTMAN Z-SCORE & DEBT/EQUITY
National Vision Holdings Inc. (NASDAQ) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: EYE 2
— UNH 8
■ METRIC PARITY
LAST: $16.64 (+7.63%) • MKT CAP: $1.32B
balance-sheet
—
LAST: $410.91 (+0.94%) • MKT CAP: $368.83B
balance-sheet
3.12
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (EYE VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | EYE | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 88.57% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 4.40% | 11.47% | -7.07 | UNH | /roic <GO> |
| EV/EBITDA & P/E Valuation | 12.4x | 16.4x | -4.05 | EYE | /valuation <GO> |
| Free Cash Flow Yield | 5.58% | 6.48% | -0.90 | UNH | /fcf-yield <GO> |
| Operating Margin | 3.00% | 4.82% | -1.82 | UNH | /operating-margins <GO> |
| Net Profit Margin | 1.50% | 3.14% | -1.64 | UNH | /net-margins <GO> |
| Revenue Growth (YoY) | 9.00% | 6.46% | +2.54 | EYE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.28% | -2.28 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | — | 3.12 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 6.74% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 45.6 | 59.2 | -13.60 | UNH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.33 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 41.3x | 17.1x | +24.21 | UNH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.32B | $368.83B | -$367.51B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | EYE REV | UNH REV | EYE GROSS % | UNH GROSS % | EYE FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.99B | $447.57B | — | 88.7% | $73.5M | $16.07B |
| FY 2024 | $1.82B | $400.28B | — | 88.3% | $38.1M | $20.70B |
| FY 2023 | $1.76B | $371.62B | — | 89.6% | $173.0M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
EYE // BETA —
UNH // BETA 0.33